GSKGSK plc
1882.00GBP-2.00%Mkt Cap: 98.67B $P/E: 16.28

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States…

Key Statistics

Company
Market Cap98.67B $
Enterprise Value117.58B $
Revenue (TTM)42.59B $
Gross Profit30.33B $
Net Income (TTM)7.33B $
Revenue/Share10.59 USD
Last Price1882.00 GBP
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees66.8K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN
Valuation
P/E (Trailing)16.28
P/E (Forward)9.82
PEG102.72
EV/EBITDA8.47
EV/Revenue2.76
P/S2.27
P/B4.28
EPS (TTM)1.18
EPS (Forward)1.92
52W Range
1288.6060% of range2282.00
52W High2282.00 GBP
52W Low1288.60 GBP
Profitability
Gross Margin72.40%
Oper. Margin30.94%
EBITDA Margin32.58%
Profit Margin17.50%
ROE34.90%
ROA9.35%
Growth
Revenue Growth5.30%
Earnings Growth-69.50%
Cash Flow & Leverage
Operating CF9.93B $
CapEx (TTM)3.83B $
FCF Margin10.49%
FCF Yield4.53%
Net Debt19.48B $
Net Debt/EBITDA1.40
Balance Sheet
Debt/Equity1.08
Current Ratio0.81
Quick Ratio0.52
Book Value/Sh4.404 GBP
Cash/Share0.7750 GBP
Dividends
Fwd Div Rate0.6800 GBP
Trail. Div Rate0.6800 GBP
Div. Yield3.55%
5Y Avg Yield4.30%
Payout Ratio56.88%
Ex-Div DateAug 13, 2026
Pay Date
Splits
Last Split4:5
Split DateJul 19, 2022
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)2161.30 GBP
Upside (mean)+14.8%
Target Range1455.00 GBP3010.00 GBP
GBP1455.00+14.8% to meanGBP3010.00
# Analysts20
Ownership
Shares Out.4.01B
Float3.88B
Insiders1.75%
Institutions48.18%
Technical
SMA 501939.41 (-3.0%)
SMA 2001949.31 (-3.5%)
Beta0.29
S&P 52W Chg18.16%
Avg Vol (30d)6.31M
Avg Vol (10d)5.52M
Technical Indicators
RSI (14)49.9
MACD-13.2913
MACD Signal-11.3151
MACD Hist.-1.9762
BB Upper2013.56 GBP
BB Middle1923.58 GBP
BB Lower1833.59 GBP
BB Width9.36%
ATR (14)56.02 GBP
Vol Ratio (20d)0.55x